The University of Chicago Header Logo

Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors.

Major Advancements in Slowing Diabetic Kidney Disease Progression: Focus on SGLT2 Inhibitors. Am J Kidney Dis. 2019 11; 74(5):573-575.

View in: PubMed